Phase 2 Airway Disease Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
COPDCOPD ExacerbationImmune System Disorder+2 more
Asger Sverrild80 enrolled2 locationsNCT05507242
Completed
Phase 2
An oral killed non-typeable Haemophilus influenzae vaccine for preventing episodes of acute bronchitis in patients with mild to moderate airways disease: Safety and efficacy study
Acute bronchitis in mild to moderate airway disease
Hunter Immunology Ltd124 enrolled1 locationACTRN12606000076572
Completed
Phase 2
An oral killed Non-typeable Haemophilus influenzae vaccine for preventing episodes of acute bronchitis in patients with moderate to severe airways disease: Safety and efficacy study
Acute bronchitis in moderate to severe airway disease
Hunter Immunology Ltd124 enrolled1 locationACTRN12606000074594